Stereoselective Diamine Synthesis via Intramolecular Cyclization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing methods for producing FXa inhibitors, such as compound (X), face challenges due to the use of hazardous azide reagents and the generation of stereoisomers, which require complex purification steps, making large-scale production inefficient and costly.
Innovation Solution
A novel method is developed that bypasses the use of azide intermediates by directly introducing a diamino skeleton through stereoselective intramolecular cyclization and desulfonylation, allowing for the regioselective production of compound (1a) and (1) with high yield and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the existing method using azide intermediates is used to produce FXa inhibitors, then the production process is established and can be scaled, but hazardous reagents are required and complex purification steps are needed to remove trans-isomers
Solution Approach 1:
The invention extracts and removes the hazardous azide intermediate step from the synthesis pathway. Instead of using azide compounds to introduce the amino group, the patent employs a direct aminomethylation reaction that introduces the amino group without forming azide intermediates, thereby eliminating the need to handle dangerous reagents while maintaining production reliability
Solution Approach 2:
The patent introduces a new intermediary reaction mechanism - the aminomethylation reaction using formaldehyde and ammonia sources - that serves as a safe alternative to the hazardous azide pathway. This intermediary process achieves the same synthetic goal (introducing amino groups) without requiring dangerous reagents or subsequent reduction steps
2Reliability
If the existing method using azide intermediates is used to produce FXa inhibitors, then the production process is established, but complex purification steps are required to isolate cis-isomers from trans-isomers
Solution Approach 1:
The invention performs preliminary action by designing a stereoselective synthesis pathway that prevents the formation of trans-isomers from the beginning. The intramolecular cyclization reaction is designed to proceed with high cis-selectivity, so that the desired cis-isomer is formed preferentially without requiring subsequent separation from trans-isomers
Solution Approach 2:
The patent changes the reaction parameters and mechanism - specifically using intramolecular cyclization under controlled conditions with specific catalysts and temperature ranges - to alter the stereochemical outcome. This parameter optimization achieves high cis-isomer selectivity (95% or higher) directly in the reaction, eliminating the need for complex purification steps
3Reliability
If the existing method using azide intermediates and multiple purification steps is used, then FXa inhibitors can be produced, but production efficiency is reduced and costs increase
Solution Approach 1:
The invention enables continuous production by eliminating the discontinuous purification steps required in the azide method. The streamlined process flows directly from cyclization to product isolation without interruption for chromatographic separations, maintaining continuous material flow and improving overall production efficiency while ensuring product quality
Solution Approach 2:
The patent extracts and removes the time-consuming and costly purification steps from the production process. By achieving high stereoselectivity in the cyclization reaction, the method eliminates the need for silica gel column chromatography or other complex separation techniques, thereby improving productivity and reducing production costs while maintaining product quality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables an efficient and industrial-scale production of FXa inhibitors (X) and (X-a) without the need for hazardous reagents and complex purification, improving yield and reducing production costs.
Implementation Method 1
constructing a stereoselective (3aR,7aS)-octahydro-2,1,3-benzothiadiazole ring, utilizing an intramolecular cyclization substitution reaction
Implementation Method 2
performing desulfonylation to remove a sulfonyl group from a sulfamoyl partial structure
Data Source
AI summary
The problem to be solved is to provide a method for efficiently producing compounds (1) and (1a) that are important intermediate compounds in the production of FXa inhibitors (X) and (X-a). The solutions thereto are a method for producing a compound represented by the formula (8d) using a stereoselective intramolecular cyclization reaction, and a method for producing a compound (If) or a salt thereof, or a hydrate thereof, which is characterized by desulfonylation of the compound (8d). In each formula, R4a represents a C1-C6 alkyl group, a benzyl group, etc.